Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

antiviral treatments

- PMLiVE

Standard steroid improves recovery of critically-ill COVID-19 patients

The study evaluated hydrocortisone in 403 patients with suspected or confirmed COVID-19

Roche Basel Switzerland

Roche’s Tamiflu successor hits the mark in complicated flu

Baloxavir marboxil met its primary objective and cut flu-related complications

- PMLiVE

Pharma trio join with top universities for new drug search

AZ, GSK and J&J join forces with Imperial, University College and Cambridge

- PMLiVE

BioCryst gets FDA nod for first intravenous flu drug

Expects to launch Rapivab in time for this year's flu season

- PMLiVE

Text messages studied as tool for cutting type 2 diabetes risk

Imperial College London teams up with Rapide

Text messaging fails to change stance on flu vaccine

US study of low-income, pregnant women indicates texting ineffective in changing willingness to have flu vaccine

- PMLiVE

NHS Trust uses 50’s-style ad campaign to spread flu jab message

Collaborates with Liverpool-based agency Splinter on immunisation adverts

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links